.Nature Medication, Posted online: 30 July 2024 doi:10.1038/ d41591-024-00054-wThe antibody-- medicine conjugate (ADC) tisotumab vedotin resulted in strengthened progression-free as well as general survival, leading to FDA approval and also a brand-new therapy alternative for people.